| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 39.8 | 33.3 | 26.6 |
| Total income | 39.9 | 33.3 | 26.6 |
| Profit before exceptional items & tax | 6.2 | 6.0 | 4.9 |
| Profit before tax | 6.2 | 6.0 | 4.9 |
| Net profit | 4.5 | 4.5 | 3.7 |
| Operating margin | 15.5% | 18.0% | 18.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +21.60% |
|---|---|
| Net profit, quarter on quarter | +0.00% |
| Revenue, year on year | +49.60% |
BSE results filing, BSE: 543963. Figures extracted from the filing.
Shelter Pharma Ltd: key numbers
- Share price
- ₹37.47
- Market cap
- ₹63.09 Cr
- Revenue (annual)
- ₹73.13 Cr
- Net profit (annual)
- ₹9.03 Cr
- P/E (TTM)
- 7.0×Sector 47.4×
- Promoter holding
- 44.38%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shelter Pharma Ltd
All →Shelter Pharma Bags ₹0.1 Cr Order from Berlin International Company
Shelter Pharma received a ₹0.10 Cr export order from Berlin International Company for D3 CURE nutraceuticals. The order broadens its global nutraceutical customer base.
- Value
- ₹0.10 Cr
- From
- Berlin International Company
- Execution
- mutually agreed timelines as per purchase order schedule
Shelter Pharma Business Update
Shelter Pharma will participate in the Vishwa Ayurveda Parishad Exhibition in Jaipur on 17-18 September 2026. The company secured a stall to showcase its pharmaceutical and Ayurveda product portfolio.
Shelter Pharma Annual Report
Shelter Pharma Ltd has filed its 19th Annual Report for the financial year 2025-26 in compliance with SEBI (LODR) regulations.
Shelter Pharma Annual General Meeting
Shelter Pharma Limited announced its 19th Annual General Meeting for September 29, 2026. The board also approved the regularisation of Ms. Vinita Shivraj Gadhvi as Independent Director.
Shelter Pharma Management Change
Shelter Pharma Limited announced the regularization of Ms. Vinita Shivraj Gadhavi as a Non-Executive Independent Director. The Board also approved the notice for the 19th AGM.
Shelter Pharma Business Update
Shelter Pharma Limited completed and dispatched a nutraceutical export order worth USD 139,200 to Sudan. The client is Taha Drugs & Chemicals Co. Ltd.
- Value
- ₹1.32 Cr